Cargando…

Oral Cholera Vaccine Efficacy and Effectiveness

Although measuring vaccine efficacy through the conventional phase III study design, randomized, double-blinded controlled trial serves as the “gold standard”, effectiveness studies, conducted in the context of a public health program, seek to broaden the understanding of the impact of a vaccine in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Katerina Rok, Lim, Jacqueline Kyungah, Park, Se Eun, Saluja, Tarun, Cho, Sung-Il, Wartel, Tram Anh, Lynch, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708586/ https://www.ncbi.nlm.nih.gov/pubmed/34960228 http://dx.doi.org/10.3390/vaccines9121482

Ejemplares similares

Review on the Recent Advances on Typhoid Vaccine Development and Challenges Ahead
por: Syed, Khalid Ali, et al.
Publicado: (2020)

Statistical considerations on real time and extended controlled temperature conditions (ECTC) stability data analysis of vaccines
por: Kim, Deok Ryun, et al.
Publicado: (2023)

Hepatitis E vaccine—Illuminating the barriers to use
por: Lynch, Julia A., et al.
Publicado: (2023)

Oral Cholera Vaccine Development and Use in Vietnam
por: Anh, Dang Duc, et al.
Publicado: (2014)

The opportunities & challenges in delivering oral cholera vaccines
por: Deen, Jacqueline, et al.
Publicado: (2016)

Review of oral cholera vaccines: efficacy in young children
por: Aumatell, Cristina Masuet, et al.
Publicado: (2011)

The case for ring vaccinations with special consideration of oral cholera vaccines
por: Deen, Jacqueline, et al.
Publicado: (2018)

The Case for Reactive Mass Oral Cholera Vaccinations
por: Reyburn, Rita, et al.
Publicado: (2011)

Oral cholera vaccine in cholera prevention and control, Malawi
por: M’bangombe, Maurice, et al.
Publicado: (2018)

Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal
por: Chapagain, Ram Hari, et al.
Publicado: (2023)

Post-licensure deployment of oral cholera vaccines: a systematic review
por: Martin, Stephen, et al.
Publicado: (2014)

Controlling Endemic Cholera with Oral Vaccines
por: Longini, Ira M, et al.
Publicado: (2007)

Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine
por: Levine, Myron M
Publicado: (2010)

Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment
por: Deen, Jacqueline, et al.
Publicado: (2021)

Use of oral cholera vaccine as a vaccine probe to determine the burden of culture-negative cholera
por: Im, Justin, et al.
Publicado: (2019)

Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India
por: Raghava Mohan, Venkata, et al.
Publicado: (2019)

Vaccination Strategies to Combat an Infectious Globe: Oral Cholera Vaccines
por: López-Gigosos, Rosa M, et al.
Publicado: (2011)

Use of Oral Cholera Vaccines in an Outbreak in Vietnam: A Case Control Study
por: Anh, Dang Duc, et al.
Publicado: (2011)

Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool)
por: Morgan, Winthrop, et al.
Publicado: (2020)

Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal
por: Chapagain, Ram Hari, et al.
Publicado: (2022)

Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010–2011
por: von Seidlein, Lorenz, et al.
Publicado: (2012)

Methods to Assess the Impact of Mass Oral Cholera Vaccination Campaigns under Real Field Conditions
por: Deen, Jacqueline, et al.
Publicado: (2014)

Use of oral cholera vaccine as a vaccine probe to define the geographical dimensions of person-to-person transmission of cholera
por: Ali, Mohammad, et al.
Publicado: (2018)

Oral cholera vaccines and their impact on the global burden of disease
por: Wierzba, Thomas F.
Publicado: (2018)

Willingness to pay for oral cholera vaccines in urban Bangladesh
por: Sarker, Abdur Razzaque, et al.
Publicado: (2020)

Challenges for Programmatic Implementation of Oral Cholera Vaccine in India
por: Chakraborty, Debjit, et al.
Publicado: (2021)

Why is the oral cholera vaccine not considered an option for prevention of cholera in India? Analysis of possible reasons
por: Gupta, Sanjukta Sen, et al.
Publicado: (2016)

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy
por: Rabaa, Maia A, et al.
Publicado: (2017)

Overview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans
por: Sahastrabuddhe, Sushant, et al.
Publicado: (2019)

The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships
por: Odevall, Lina, et al.
Publicado: (2018)

Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine
por: Akter, Aklima, et al.
Publicado: (2021)

Knowledge, Attitudes, and Practices regarding Diarrhea and Cholera following an Oral Cholera Vaccination Campaign in the Solomon Islands
por: Burnett, Eleanor, et al.
Publicado: (2016)

Crisis-driven cholera resurgence switches focus to oral vaccine
Publicado: (2018)

Controlling cholera in the Ouest Department of Haiti using oral vaccines
por: Kirpich, Alexander, et al.
Publicado: (2017)

An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease
por: Meunier, Marine, et al.
Publicado: (2023)

The Role of Vaccine Coverage within Social Networks in Cholera Vaccine Efficacy
por: Root, Elisabeth D., et al.
Publicado: (2011)

Safety of the Recombinant Cholera Toxin B Subunit, Killed Whole-Cell (rBS-WC) Oral Cholera Vaccine in Pregnancy
por: Hashim, Ramadhan, et al.
Publicado: (2012)

Feasibility of Mass Vaccination Campaign with Oral Cholera Vaccines in Response to an Outbreak in Guinea
por: Ciglenecki, Iza, et al.
Publicado: (2013)

A randomized, observer-blind, controlled phase III clinical trial assessing safety and immunological non-inferiority of Vi-diphtheria toxoid versus Vi-tetanus toxoid typhoid conjugate vaccine in healthy volunteers in eastern Nepal
por: Chaudhary, Shipra, et al.
Publicado: (2023)

Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines
por: Albutti, Aqel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hpdtv36h4jfj6rl3tm5p1hdmr1